福森藥業有限公司 01652Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name福森藥業有限公司
Stock Code01652
Company Full Name福森藥業有限公司
Industry醫療保健
Principal Activities公司主要於中國從事制造及銷售藥品。
Listing Date2018-07-11
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國河南省淅川縣城區工業園區
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttp://www.fusenyy.com
Share Registrar香港中央證券登記有限公司
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
// Offering Information //
Prospectus Date2018-06-28
Offer PriceHK$ 2.08 / shares
Total Funds RaisedHK$ 41,600,000
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 2.33
First Day Change22.12%
First Day Volume72934000.0
First Day Turnover180523000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約30%或112.4百萬港元將用于擴充計劃; 2、約10%或37.4百萬港元將用于產品廣告及營銷; 3、約10%或37.4百萬港元將用于擴展現有營銷及分銷網絡,以提高市場滲透水平,覆蓋更多最終客戶,從而增加市場占有率; 4、約10%或37.4百萬港元將用于繼續進行研究及開發活動,尤其是為與外部合作伙伴合作進行的研究項目提供資金; 5、約15%或56.1百萬港元將用于并購治療領域與我們目前重點治療領域類似的中成藥飲片及顆粒劑或其他西藥生產商,以拓展產品組合及增強競爭優勢; 6、約15%或56.1百萬港元將用作收購中成藥或其他西藥的生產許可證,以拓展產品組合; 7、約10%或約37.4百萬港元將用于為營運資金及其他一般企業用途提供資金。
// Underwriting Syndicate //
独家保荐人 (1)
中信建投(国际)融资有限公司
整体协调人 (3)
中信建投(国际)融资有限公司 农银国际融资有限公司 蓝山证券有限公司
联席账簿管理人 (6)
中信建投(国际)融资有限公司 农银国际融资有限公司 蓝山证券有限公司 东兴证券(香港)有限公司 联合证券有限公司 广发证券(香港)经纪有限公司
联席牵头经办人 (6)
中信建投(国际)融资有限公司 农银国际证券有限公司 蓝山证券有限公司 东兴证券(香港)有限公司 联合证券有限公司 广发证券(香港)经纪有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
Chairman曹智銘
Company Secretary楊育康
No director data available.
// Major Shareholders //
Major Shareholders & Holdings曹長城及家族成員(70.13%);Vistra Trust (Hong Kong) Limited(23.91%);林曉波(5.27%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics